Talk:WikiJournal of Medicine/Hepatitis E

From Wikiversity
Jump to navigation Jump to search

WikiJournal of Medicine logo.svg

WikiJournal of Medicine
Wikipedia-integrated • Public peer review • Libre open access

WikiJournal of Medicine is an open-access, free-to-publish, Wikipedia-integrated academic journal for Medical and Biomedical topics. <seo title=" WJM, WikiJMed, Wiki.J.Med., WikiJMed, Wikiversity Journal of Medicine, WikiJournal Medicine, Wikipedia Medicine, Wikipedia medical journal, WikiMed, Wikimedicine, Wikimedical, Medicine, Biomedicine, Free to publish, Open access, Open-access, Non-profit, online journal, Public peer review "/>

<meta name='citation_doi' value='10.15347/wjm/2019.003'>

Article information

Author: Ozzie Anis[i]ORCID iD.svg , et al.

Anis, O; et al.. 




 


Plagiarism check

WMF copyvio tool using TurnItIn. There was one duplicate sentence that was detected and I recommend rephrasing or explicitly attributing as a quote.

"Laboratory animal care personnel, researchers, and support staff represent a new population at risk for HEV infection, and research facilities should be diligent in measures to prevention of this possibly zoonotic pathogen"
Birke, Leslie; Cormier, Stephania A.; You, Dahui; Stout, Rhett W.; Clement, Christian; Johnson, Merlin; Thompson, Hilary (2014-4). "Hepatitis E Antibodies in Laboratory Rabbits from 2 US Vendors". Emerging Infectious Diseases 20 (4): 693–696. doi:10.3201/eid2004.131229. ISSN 1080-6040. PMID 24655426. PMC PMC3966401. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966401/. 

Other short, common phrases were detected such as "The incubation period following exposure to the hepatitis E virus ranges from..." but were not regarded as plagiarism. T.Shafee(Evo﹠Evo)talk 02:00, 4 November 2018 (UTC)

done[1], thank you for pointing it out,--Ozzie10aaaa (discusscontribs) 13:47, 4 November 2018 (UTC)
Artículo bueno.svg Pass. T.Shafee(Evo﹠Evo)talk 23:59, 4 November 2018 (UTC)

Contacting the authors

Although Ozzie would be the corresponding author, I would insist on caring to leave a message on the talk pages of the 2 other editors who have made more than 20 edits to the page. The objective of this message is to invite the contributors to collaboratively submit the article for review through Wiki.J.Med, and if possible, to help in further betterment of the article in accordance to the suggestions of the reviewers. Wikipedia articles are collaboratively authored. So, it is very important to make the authors aware of such a process that the article is currently undergoing. Diptanshu 💬 12:33, 3 November 2018 (UTC)

done..contacted both[2][3]--Ozzie10aaaa (discusscontribs) 16:56, 3 November 2018 (UTC)

First peer review

Review by Premashis Kar , Departments of Obstetrics & Gynaecology, Maulana Azad Medical College, University of Delhi
This review was submitted on , and refers to this previous version of the article


The paper is well written, it is comprehensive with referrence to the epidemiology, clinical features, diagnosis, cause of the disease, treatment and preventive approaches. The context of the paper which describes the animal reservior, historical aspects and the recent outbreaks should be reduced to few lines. The modified paper should be considered for publication.

Response
This is a valuable review and have gone about the recommended changes:

  • 'Animal reservoir' have reduced to more essential aspect of animal reservoir for Hepatitis E
  • 'History' have condensed to most essential 'historical' aspects of Hepatitis E
  • 'Recent outbreaks' have slightly reduced the 'outbreak' section, do not agree with a further trim, as the Kitgum District of northern Uganda should remain due to the importance of outbreak as well as, more recent outbreaks of Hepatitis E

I believe I have addressed the specific comments, I would like to thank you for your valuable time and recommendations --Ozzie10aaaa (discusscontribs) 20:53, 23 November 2018 (UTC)

Second peer review

Hepatitis E - María Teresa Pérez Gracia Revision.pdf

A

Reviewer-annotated pdf file.

Review by María Teresa Pérez-Gracia , Universidad CEU Cardenal Herrera
This review was submitted on , and refers to this previous version of the article


Reviewer comments submitted as PDF


Response
This is a valuable review and have gone about some of the recommended changes:

1.While this is helpful:

the World Health Organization officially indicates 5 types per:

  • "WHO | What is hepatitis?". WHO. Retrieved 18 December 2018.
  • "WHO | Types of hepatitis". WHO. Retrieved 18 December 2018.


2. Has been answered as follows:

  • Acute pancreatitis was already in the text
  • Haematological manifestations was already in the text in the form of thrombocytopenia, and cryoglobulinemia
  • Autoimmune phenomena was already in text in the form of Glomerulonephritis
  • PNS neurological syndromes was already in text in the form of Guillain-Barré syndrome
  • have added - CNS neurological syndromes as suggested

3.per #3 on PDF, only has text without a clear suggestion for the classification subsection(and distribution), therefore only added first sentence & reference indicated on pdf..("Hepatitis E". www.who.int. Retrieved 8 January 2019. ... WHO indicates 4 genotypes)

4.Done as suggested

5./6. Done, however the article suggested as reference indicates 'Conflict of interest statement'

  • Q.D. and A.P. have filed a patent application on the use of the HEV transcomplementation system and ORF3’s ion channel function for anti-HEV drug screening.

7.Done as suggested


I believe I have addressed the specific comments,however if #3 needs to be further reviewed/responded I would be more than happy to, I would like to thank you for your valuable time and recommendations--Ozzie10aaaa (discusscontribs) 15:58, 18 December 2018 (UTC)

Third peer review

Review by Esther Aspinall , Health Protection Scotland
This review was submitted on , and refers to this previous version of the article


Review of epidemiology section:

Line 1: Would possibly be more accurate to use the wording ‘resulted in 57,000 deaths during 2010’

Line 2: Suggested wording: ‘pregnant women are particularly at risk of complications due to HEV infection’. The high mortality rate is among women in low income settings – in some high income settings it is unclear if mortality rate among pregnant women is any different than among non-pregnant women https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575020/ I would not use the term lethal in relation to an infectious disease: suggest using term ‘fatal’

Line 4: Reference 52 refers to HEV in pregnancy – another reference is needed for the sentence regarding Central Asia and Central America

Line 5: The reference to England & Wales is now significantly out of date (2005) – data up to 2015 is available at https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/500321/hpr0616_zoos.pdf This is also a well-documented European trend, see: https://ecdc.europa.eu/sites/portal/files/documents/HEV_Surveillance-report-2005-2015.pdf https://www.ncbi.nlm.nih.gov/pubmed/28681720

Line 5: largest ‘known’ outbreak would be more accurate Line 9: reference 57: page not found General comment: WHO now use the term low/middle/high income settings rather than ‘developed’/’developing’ countries


Response
This is a valuable review and have gone about the recommended changes:

1.Done as suggested

2.Done as suggested

3.With regards to-


4.Added- "Common animal associated infections quarterly report (England and Wales) – fourth quarter 2015". assets.publishing.service.gov.uk 10 (6). 12 February, 2016. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/500321/hpr0616_zoos.pdf. Retrieved 8 January 2019. 

5.Have addressed both points as follows-

  • Done as suggested
  • and Dead link fixed/replaced


I believe I have addressed the specific comments,however if there is anything further that needs to be reviewed/responded I would be more than happy to, I would like to thank you for your valuable time and recommendations--Ozzie10aaaa (discusscontribs) 04:51, 8 January 2019 (UTC)


Fourth peer reviewer

WikiJournal Preprints Hepatitis E corr. pischke.pdf

A

Reviewer-annotated pdf file.

Review by Sven Pischke , University Medical Center Hamburg-Eppendorf
This review was submitted on , and refers to this previous version of the article


Reviewer comments submitted as PDF (as annotations)


Response
This is a valuable review and have gone about some of the recommended changes:

1.Done as suggested

2.Indicated genotypes 3 and 4 ( HEV in women who are pregnant already mentioned)

3.Done as suggested, with additional reference

4.Done as suggested, with additional reference

5.Done as suggested, with additional reference

6.'Classification' do not agree suggested text should go in this section, however further down to one of the subsections would be more cogent

7.Done as suggested

8.Done as suggested, with additional references

9.Done as suggested, with additional references

10.The CDC has several images available, however I felt it would be best to put the emphasis on text/information rather than too many images (all CDC images are so referenced)

11.Have included -Rein, David B.; Stevens, Gretchen A.; Theaker, Jordan; Wittenborn, John S.; Wiersma, Steven T. (2012). "The global burden of hepatitis E virus genotypes 1 and 2 in 2005" (in en). Hepatology 55 (4): 988–997. doi:10.1002/hep.25505. ISSN 1527-3350. https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.25505. Retrieved 15 January 2019. 

12.'Animal reservoir' section would not benefit from further text/information (however should you feel it should be added I would therefore do so)

13.Done as suggested

14.a.Done as suggested, with additional references

14.b.Done as suggested (small section)

15.This outbreak is already covered in the text

I believe I have addressed the specific comments,however if 6, or 12 needs to be reviewed/responded I would be more than happy to, I would like to thank you for your valuable time and recommendations--Ozzie10aaaa (discusscontribs) 00:01, 16 January 2019 (UTC)

Review by Sven Pischke ,
This review


The current version of the paper is not completely right. they state there are 4 genotypes but this is not true (this classification has changed approximately 2 years ago). the present calssification divides HEV genotypes into GT 1-4 and 5, 6, 7, 8 (wild boar, wild boar, camels, camels).

The remaining changes are right.

Response
Have added per the following reference:

Thank you for your valuable time and recommendation--Ozzie10aaaa (discusscontribs) 01:57, 17 January 2019 (UTC)

Editorial comments

Comments by Thomas Shafee
These comments were submitted on , and refer to this previous version of the article

Comments from the editorial board discussion:

  • Could the author please add their ORCID (registration page if they do not already have one).
  • Some of the key references are dated e.g. over 10 years old. Could the author please check if more recent alternatives are available for the older sources.
    • E.g. The estimates for newly infected persons are from 2013, although more recent data is available [4] (note, hepatitis estimation process changed).

Response
Dr. Shafee

Should there be any further references, that are dated and have a new version which I might have missed, I would therefore unhesitantly add, thank you--Ozzie10aaaa (discusscontribs) 12:15, 30 January 2019 (UTC)

 

Comments by Mikael Häggström
These comments were submitted on , and refer to this previous version of the article

Hello Ozzie

In further editorial board discussions, it was pointed out that the following section is in need of a more recent reference as well:

  • "The hepatitis E virus causes around 20 million infections a year. These result in around three million acute illnesses and resulted in 57,000 deaths during 2010.[1]

Best regards,

Mikael Häggström (discusscontribs) 18:53, 5 February 2019 (UTC)

ref
  1. Lozano, Rafael; Naghavi, Mohsen; Foreman, Kyle; Lim, Stephen; Shibuya, Kenji; Aboyans, Victor; Abraham, Jerry; Adair, Timothy et al. (15 December 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet (London, England) 380 (9859): 2095–2128. doi:10.1016/S0140-6736(12)61728-0. ISSN 1474-547X. https://www.ncbi.nlm.nih.gov/pubmed/23245604. Retrieved 30 October 2018. 

Response
Dr. Häggström

Upon reviewing the text a WHO reference that had been used for a different section can readily be used in this case-

Should there be any further references, that are dated and have a newer version which I might have missed, I would therefore unhesitantly add, thank you--Ozzie10aaaa (discusscontribs) 21:09, 5 February 2019 (UTC)

 

Comments by Mikael Häggström
These comments were submitted on , and refer to this previous version of the article

Hello Ozzie

Thank you. Actually, we also noted reference 3 and 4 were retrieved 2016, but these pages have since been updated 2018. Could you check whether the information is still correct, and if so, update the retrieval date?

Best regards,

Mikael Häggström (discusscontribs) 21:25, 5 February 2019 (UTC)

Response
Dr. Häggström

thank you--Ozzie10aaaa (discusscontribs) 00:54, 6 February 2019 (UTC)

Fifth peer review

A fifth reviewer was contacted specifically to request comment on the article's references.

Review by Richie Madden , Cornwall Hospital Trust and European Centre for Environment and Human Health, University of Exeter
This review was submitted on , and refers to this previous version of the article


More than happy to comment on the references. Key Papers in Hepatitis E include:

Neurological associations

1*Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Mansuy JM, et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011;17:173–179.

2*Dalton HR, Kamar N, van Eijk JJ, McLean BN, Cintas P, Bendall RP, et al. Hepatitis E virus and neurological injury. Nat Rev Neurol 2016;12:77–85.

3*van Eijk JJ, Madden RG, van der Eijk AA, Hunter JG, Reimerink JH, Bendall RP, et al. Neuralgic amyotrophy and hepatitis E virus infection. Neurology 2014;82:498–503.

4*van Eijk JJJ, Dalton HR, Ripellino P, Madden RG, Jones C, Fritz M, et al. Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophy. Neurology 2017;89(9):909–991.

5*Dalton HR, van Eijk JJ, Cintas P, Madden R, Jones C, Webb G, et al. Hepatitis E infection and acute non-traumatic neurological injury: A prospective pilot multicenter study. J Hepatol 2017;67:925–932.

6*van den Berg B, van der Eijk AA, Pas SD, Hunter JG, Madden RG, Tio- Gillen AP, et al. Guillain-Barre syndrome associated with preceding hepatitis E virus infection. Neurology 2014;82:491–497.

Solid organ transplant

7*Kamar N, Weclawiack H, Guilbeaud-Frugier C, Legrand-Abravanel F, Cointault O, Ribes D, et al. Hepatitis E virus and the kidney in solidorgan- transplant patients. Transplantation 2012;93:617–623.

8*Dalton HR, Bendall R, Keane F, Tedder R, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009;361:1025–1027.

Extra-hepatic manifestations

9*Woolson KL, Forbes A, Vine L, Beynon L, McElhinney L, Panayi V, et al. Extra-hepatic manifestations of autochthonous hepatitis E infection. Aliment Pharmacol Ther 2014;40:1282–1291.

10*Pischke S, Polywka S, Haag F, Iking-Konert C, Sterneck M, Lutgehetmann M, et al. Association of hepatitis E virus and essential cryoglobulinemia? J Clin Virol 2015;67:23–24.

11*Pischke S, Behrendt P, Manns MP, Wedemeyer H. HEV-associated cryoglobulinaemia and extrahepatic manifestations of hepatitis E. Lancet Infect Dis 2014;14:678–679.

Assays

12*Bendall R, Ellis V, Ijaz S, Ali R, Dalton HR. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti- HEV IgG seroprevalence data in developed countries. J Med Virol 2010;82:799–805.

13*Baylis SA, Blumel J, Mizusawa S, Matsubayashi K, Sakata H, Okada Y, et al. World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA. Emerg Infect Dis 2013;19:729–735.

Treatment and prevention

14*Peron JM, Dalton HR, Izopet J, Kamar N. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? J Hepatol 2011;54:1323–1324, [Author reply 1324–1325].

15*Kamar N, Rostaing L, Abravanel F, Garrouste C, Esposito L, Cardeau- Desangles I, et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010;50:e30–e33.

16*Haagsma EB, Riezebos-Brilman A, van den Berg AP, Porte RJ, Niesters HG. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl 2010;16:474–477

17*Wu T, Zhu FC, Huang SJ, Zhang XF, Wang ZZ, Zhang J, et al. Safety of the hepatitis E vaccine for pregnant women: a preliminary analysis. Hepatology 2012;55:2038.

18*Mallet V, Nicand E, Sultanik P, Chakvetadze C, Tesse S, Thervet E, et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010;153:85–89.

19*Kamar N, Lhomme S, Abravanel F, Cointault O, Esposito L, Cardeau- Desangles I, et al. An early viral response predicts the virological response to ribavirin in hepatitis E virus organ transplant patients. Transplantation 2015;99:2124–2131.

20*Alric L, Bonnet D, Laurent G, Kamar N, Izopet J. Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-alpha therapy. Ann Intern Med 2010;153:135–136. Africa and HIV

21*Keane F, Gompels M, Bendall R, Drayton R, Jennings L, Black J, et al. Hepatitis E virus coinfection in patients with HIV infection. HIV Med 2012;13:83–88.

22*Dalton HR, Keane F, Bendall R, Mathew J, Ijaz S. Treatment of chronic hepatitis E in a HIV positive patient. Ann Intern Med 2011;155:479–480.

23*Madden RG, Wallace S, Sonderup M, Korsman S, Chivese T, Gavine B, et al. Hepatitis E virus: Western Cape, South Africa. World J Gastroenterol 2016;22:9853–9859.

Blood transfusion

24*Stramer SL, Moritz ED, Foster GA, Ong E, Linnen JM, Hogema BM, et al. Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors. Transfusion 2016;56:481–488.

25*Cleland A, Smith L, Crossan C, Blatchford O, Dalton HR, Scobie L, et al. Hepatitis E virus in Scottish blood donors. Vox Sang 2013;105:283–289.

26*Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014;384: 1766–1773.

27*Mansuy JM, Gallian P, Dimeglio C, Saune K, Arnaud C, Pelletier B, et al. A nationwide survey of hepatitis E viral infection in French blood donors. Hepatology 2016;63:1145–1154.

28*Holm DK, Moessner BK, Engle RE, Zaaijer HL, Georgsen J, Purcell RH, et al. Declining prevalence of hepatitis E antibodies among Danish blood donors. Transfusion 2015;55:1662–1667.

29*Lucarelli C, Spada E, Taliani G, Chionne P, Madonna E, Marcantonio C, et al. High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014. Euro Surveill 2016;21.

At risk groups

30*Dalton HR, Fellows HJ, Stableforth W, Joseph M, Thurairajah PH, Warshow U, et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007;26:1429–1435.

31*Blasco-Perrin H, Madden RG, Stanley A, Crossan C, Hunter JG, Vine L, et al. Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK/French study. Aliment Pharmacol Ther 2015;42:574–581.

32*Brown A, Halliday JS, Swadling L, Madden RG, Bendall R, Hunter JG, et al. Characterization of the specificity, functionality, and durability of host T-cell responses

Response

  • This is a valuable review and have gone about some of the recommendations (have contacted Dr Shafee for clarification)
  • per "Wikipedia:Identifying reliable sources (medicine)". Wikipedia. 12 March 2019. Retrieved 14 April 2019....articles should be Ideal sources for biomedical material include literature reviews or systematic reviews in reliable, third-party, published secondary sources (such as reputable medical journals)... added #1,#2,#9, and #13 the other suggested references were omitted due to being letters / case studies / not a review or systematic review per the aforementioned MEDRS (ref #30 is from 2007 where MEDRS states articles should a review that was conducted more than five or so years ago will have been superseded by more up-to-date ones, and editors should try to find those newer sources)

Thank you for your valuable time and recommendations, should there be any further suggested review articles I would not hesitate to add them, thank you again--Ozzie10aaaa (discusscontribs) 20:53, 15 April 2019 (UTC)

Editors note

Comments by Thomas Shafee
These comments were submitted on , and refer to this previous version of the article

I think that the image in figure 1 is tricky interpret. The arrows in panel A point to the virion, but those in B, C & D point to bound gold nanoparticles. It would be better to either crop to panel A or use another image (e.g. than this or one of these).

Response
Dr Shafee.. Have added your text above to explain image better- gold nanoparticles [1].The issue in that image is that the text immediately to the left works with image, pork sausage. Let me know if this is an adequate solution, thank you as always --Ozzie10aaaa (discusscontribs) 11:42, 27 July 2019 (UTC)

  1. Draz, Mohamed Shehata; Shafiee, Hadi (2018). "Applications of gold nanoparticles in virus detection". Theranostics 8 (7): 1985–2017. doi:10.7150/thno.23856. ISSN 1838-7640. https://www.ncbi.nlm.nih.gov/pubmed/29556369. Retrieved 27 July 2019. 

Comments by Thomas Shafee
I agree - that's a sensible solution.